Complete Filing Data
Allarity Therapeutics, Inc. reported Stockholders Equity of $9.83 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Allarity Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$11.2M | -$24.5M | -$11.9M | -$16.1M | -$26.6M | -$6.6M |
| Research And Development Expense | $6.6M | $6.1M | $7.1M | $6.9M | $14.2M | $4.2M |
| Operating Income Loss | -$12.6M | -$27.2M | -$17.1M | -$34.5M | -$26.6M | -$8.3M |
| Operating Expenses | $12.9M | $27.2M | $17.1M | $34.5M | $26.6M | $8.3M |
| Net Income Loss Available To Common Stockholders Basic | -$11.2M | -$25.2M | -$20.4M | -$21.1M | -$26.6M | -$6.6M |
| General And Administrative Expense | $6.3M | $11.4M | $10.0M | $10.0M | $12.4M | $4.1M |
| Comprehensive Income Net Of Tax | -$11.9M | -$24.5M | -$11.6M | -$16.2M | -$28.6M | -$4.1M |
| Income Tax Expense Benefit | $0.00 | -$381.0K | $83.0K | -$1.5M | $133.0K | $198.0K |
| Other Nonoperating Income Expense | $41.0K | $1.9M | ||||
| Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustment And Tax Noncontrolling Interest1 | $2.0M | -$2.5M | ||||
| Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax Parent | -$121.0K | -$2.0M | -$4.2M | |||
| Deferred Income Tax Expense Benefit | $97.0K | -$1.6M | $20.0K | $165.0K | ||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $667.0K | $57.0K | $310.0K | -$121.0K | -$2.0M | $2.5M |
| Deferred Income Tax Liabilities Net | $0.00 | $446.0K | $349.0K | $2.0M | $2.1M | |
| Income Tax Receivable | $838.0K | $908.0K | ||||
| Accrued Income Taxes Current | $41.0K | $60.0K | $57.0K | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$9.0K | $15.0K | ||||
| Income Taxes Paid | $6.0K | $12.0K | $118.0K | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$667.0K | $57.0K | $310.0K | -$121.0K | ||
| Revenue From Contract With Customer Including Assessed Tax | $320.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.8M | -$2.3M | -$2.7M | -$11.6M | -$1.6M | -$3.8M | -$4.4M | -$2.4M | -$3.4M | -$5.0M | -$5.1M | -$3.1M | -$1.4M | -$5.4M | -$3.1M | -$960.0K | |||
| Research And Development Expense | $1.2M | $2.3M | $1.4M | $1.0M | $1.1M | $2.2M | $1.9M | $1.1M | $1.4M | $3.0M | $1.7M | $1.3M | $1.4M | $2.3M | $1.3M | $1.0M | |||
| Operating Income Loss | -$2.5M | -$4.1M | -$3.0M | -$12.3M | -$3.4M | -$4.2M | -$4.4M | -$4.2M | -$3.7M | -$4.6M | -$4.8M | -$18.3M | -$4.0M | -$4.4M | -$2.5M | -$2.0M | |||
| Operating Expenses | $2.5M | $4.1M | $3.0M | $12.3M | $3.4M | $4.2M | $4.4M | $4.2M | $3.7M | $4.6M | $4.8M | $18.3M | $4.0M | $4.4M | $2.5M | $2.0M | |||
| Net Income Loss Available To Common Stockholders Basic | -$2.8M | -$2.3M | -$2.7M | -$12.2M | -$1.7M | -$3.9M | -$5.6M | -$9.8M | -$3.4M | -$6.7M | -$6.5M | -$4.7M | $1.7M | -$4.7M | -$3.1M | -$960.0K | -$2.0M | -$975.0K | |
| General And Administrative Expense | $1.3M | $1.8M | $1.6M | $1.6M | $2.3M | $2.1M | $2.5M | $3.1M | $2.2M | $1.6M | $3.1M | $3.0M | $2.6M | $2.1M | $1.2M | $953.0K | |||
| Comprehensive Income Net Of Tax | -$2.6M | -$4.2M | -$3.0M | -$11.8M | -$1.8M | -$3.8M | -$4.5M | -$2.4M | -$3.3M | -$5.7M | -$5.5M | -$3.3M | -$2.5M | -$5.7M | -$3.6M | $170.0K | |||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$377.0K | $0.00 | -$4.0K | $0.00 | $5.0K | $4.0K | -$1.2M | $35.0K | $30.0K | $33.0K | -$691.0K | |||||
| Other Nonoperating Income Expense | -$21.0K | $1.8M | $307.0K | -$470.0K | -$257.0K | $14.0M | $2.7M | -$990.0K | -$590.0K | -$314.0K | |||||||||
| Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustment And Tax Noncontrolling Interest1 | -$84.0K | $643.0K | $414.0K | $214.0K | $1.1M | $300.0K | $459.0K | -$1.1M | |||||||||||
| Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax Parent | $733.0K | $170.0K | |||||||||||||||||
| Deferred Income Tax Expense Benefit | -$14.0K | -$1.2M | $33.0K | ||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | -$158.0K | $1.8M | $276.0K | -$163.0K | -$144.0K | $25.0K | -$92.0K | -$29.0K | $84.0K | $643.0K | $414.0K | -$214.0K | -$459.0K | ||||||
| Deferred Income Tax Liabilities Net | $0.00 | $432.0K | $432.0K | $343.0K | $343.0K | $343.0K | $619.0K | $656.0K | $700.0K | $128.0K | |||||||||
| Income Tax Receivable | $1.6M | $1.3M | $789.0K | $1.4M | $1.3M | $1.3M | $1.5M | ||||||||||||
| Accrued Income Taxes Current | $83.0K | $23.0K | $52.0K | $54.0K | |||||||||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$3.1M | -$3.1M | |||||||||||||||||
| Income Taxes Paid | $6.0K | $1.0K | |||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $158.0K | -$1.8M | -$276.0K | -$163.0K | -$144.0K | $25.0K | -$92.0K | -$29.0K | $84.0K | -$643.0K | -$414.0K | -$214.0K | -$459.0K | ||||||
| Revenue From Contract With Customer Including Assessed Tax |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $9.8M | $11.8M | -$2.8M | -$113.0K | $18.2M | $24.4M | $20.0M |
| Liabilities Fair Value Adjustment | $17.1M | $2.1M | $2.1M | ||||
| Common Stock Value | $3.0K | $1.0K | $0.00 | $2.0K | $1.0K | $426.0K | |
| Gain Loss On Investments | -$115.0K | -$495.0K | $708.0K | ||||
| Cash And Cash Equivalents At Carrying Value | $14.7M | $19.5M | $166.0K | $2.0M | |||
| Net Loss Attributable To Common Stockholders | -$21.1M | -$26.6M | -$6.6M | ||||
| Accounts Payable Current | $4.3M | $4.2M | $8.4M | $6.3M | $698.0K | $2.1M | |
| Retained Earnings Accumulated Deficit | -$130.2M | -$119.0M | -$94.5M | -$82.6M | -$66.5M | -$39.8M | |
| Property Plant And Equipment Net | $330.0K | $309.0K | $20.0K | $21.0K | $8.0K | $21.0K | |
| Other Assets Current | $265.0K | $115.0K | $209.0K | $1.6M | $625.0K | $335.0K | |
| Liabilities Current | $8.4M | $10.8M | $14.2M | $11.2M | $20.7M | $5.5M | |
| Liabilities And Stockholders Equity | $18.3M | $22.7M | $11.9M | $14.5M | $49.6M | $33.4M | |
| Liabilities | $8.4M | $10.8M | $14.6M | $12.7M | $30.8M | $9.0M | |
| Assets Current | $17.9M | $22.3M | $2.0M | $5.0M | $21.4M | $1.7M | |
| Assets | $18.3M | $22.7M | $11.9M | $14.5M | $49.6M | $33.4M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.0M | -$354.0K | -$411.0K | -$721.0K | -$600.0K | $1.4M | |
| Accrued Liabilities Current | $2.7M | $5.2M | $1.3M | $1.9M | $8.6M | $1.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$4.2M | $19.1M | -$1.8M | -$17.3M | |||
| Change In Fair Value Of Convertible Debt | $474.0K | $573.0K | |||||
| Fair Value Adjustment Of Derivative Liabilities | -$17.1M | -$2.1M | -$2.1M | ||||
| Intangible Assets Net Excluding Goodwill | $0.00 | $9.9M | $28.1M | $30.5M | |||
| Operating Lease Liability Current | $8.0K | $98.0K | $109.0K | ||||
| Conversion Of Convertible Debt To Equity | $2.8M | $3.2M | |||||
| Other Operating Activities Cash Flow Statement | $138.0K | $238.0K | $280.0K | ||||
| Long Term Investments | $845.0K | ||||||
| Operating Lease Liability Noncurrent | $9.0K | $267.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $12.0M | $12.2M | $18.7M | $13.0M | $19.8M | -$6.5M | -$3.4M | -$723.0K | -$3.1M | $1.4M | $8.0M | $14.7M | $29.7M | $28.8M | $23.5M | $26.9M | $24.7M | $22.7M | $22.3M | |||
| Liabilities Fair Value Adjustment | $4.9M | $1.9M | $309.0K | $2.0K | $874.0K | $12.6M | $1.8M | -$25.0K | $45.0K | $104.0K | ||||||||||||
| Common Stock Value | $3.0K | $2.0K | $2.0K | $0.00 | $3.0K | $401.0K | $190.0K | $381.0K | $3.2M | $10.1M | ||||||||||||
| Gain Loss On Investments | -$45.0K | -$34.0K | -$36.0K | -$137.0K | -$67.0K | -$113.0K | -$243.0K | |||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $16.9M | $17.8M | $25.2M | $19.2M | $312.0K | $1.4M | $420.0K | $295.0K | $3.9M | $7.7M | $5.6M | $298.0K | $30.0K | $1.5M | ||||||||
| Net Loss Attributable To Common Stockholders | $1.7M | -$960.0K | ||||||||||||||||||||
| Accounts Payable Current | $4.6M | $4.6M | $4.3M | $4.7M | $7.8M | $11.1M | $6.3M | $8.1M | $6.4M | $5.6M | $5.8M | $739.0K | ||||||||||
| Retained Earnings Accumulated Deficit | -$126.8M | -$124.0M | -$121.7M | -$111.5M | -$99.9M | -$98.3M | -$92.7M | -$88.3M | -$85.9M | -$79.7M | -$74.7M | -$69.6M | -$43.4M | |||||||||
| Property Plant And Equipment Net | $330.0K | $322.0K | $308.0K | $12.0K | $17.0K | $18.0K | $29.0K | $26.0K | $25.0K | $5.0K | $5.0K | $6.0K | $9.0K | |||||||||
| Other Assets Current | $113.0K | $116.0K | $110.0K | $100.0K | $131.0K | $110.0K | $1.0M | $1.5M | $1.1M | $182.0K | $235.0K | $147.0K | $432.0K | |||||||||
| Liabilities Current | $8.8M | $9.0M | $11.1M | $7.4M | $10.6M | $18.0M | $15.7M | $12.7M | $11.6M | $13.0M | $11.5M | $12.7M | $3.8M | |||||||||
| Liabilities And Stockholders Equity | $20.8M | $21.2M | $29.7M | $20.4M | $30.9M | $12.0M | $13.9M | $13.4M | $12.7M | $18.1M | $23.2M | $31.3M | $37.0M | |||||||||
| Liabilities | $8.8M | $9.0M | $11.1M | $7.4M | $11.0M | $18.4M | $17.3M | $14.1M | $13.0M | $14.6M | $13.1M | $14.4M | $4.2M | |||||||||
| Assets Current | $20.5M | $20.9M | $29.4M | $20.4M | $21.3M | $2.3M | $4.4M | $3.7M | $3.0M | $6.1M | $10.1M | $17.2M | $7.6M | |||||||||
| Assets | $20.8M | $21.2M | $29.7M | $20.4M | $30.9M | $12.0M | $13.9M | $13.4M | $12.7M | $18.1M | $23.2M | $31.3M | $37.0M | |||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.3M | -$2.5M | -$630.0K | -$693.0K | -$530.0K | -$386.0K | -$758.0K | -$666.0K | -$637.0K | -$1.9M | -$1.2M | -$814.0K | -$419.0K | |||||||||
| Accrued Liabilities Current | $2.7M | $3.0M | $5.3M | $1.3M | $1.5M | $1.6M | $1.5M | $1.9M | $2.4M | $4.1M | $1.4M | $1.3M | $2.9M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $8.5M | -$19.0K | -$2.0M | |||||||||||||||||||
| Change In Fair Value Of Convertible Debt | $273.0K | $201.0K | -$78.0K | |||||||||||||||||||
| Fair Value Adjustment Of Derivative Liabilities | -$309.0K | -$12.6M | -$45.0K | |||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $0.00 | $9.7M | $9.7M | $9.5M | $12.0M | $12.8M | $13.7M | $28.7M | ||||||||||||||
| Operating Lease Liability Current | $29.0K | $54.0K | $82.0K | $98.0K | ||||||||||||||||||
| Conversion Of Convertible Debt To Equity | ||||||||||||||||||||||
| Other Operating Activities Cash Flow Statement | $26.0K | $24.0K | ||||||||||||||||||||
| Long Term Investments | $254.0K | $314.0K | $350.0K | $491.0K | ||||||||||||||||||
| Operating Lease Liability Noncurrent | $35.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $1.8M | $6.4M | $616.0K | |||
| Share Based Compensation | $482.0K | $71.0K | -$71.0K | $1.8M | $6.4M | $616.0K |
| Net Cash Provided By Used In Operating Activities | -$14.8M | -$17.4M | -$12.7M | -$16.8M | -$14.9M | -$7.3M |
| Increase Decrease In Prepaid Expense | $1.6M | -$274.0K | $190.0K | $618.0K | -$130.0K | -$97.0K |
| Increase Decrease In Accrued Liabilities | -$2.7M | $3.5M | $43.0K | -$4.7M | $7.2M | -$36.0K |
| Net Cash Provided By Used In Financing Activities | $10.6M | $36.8M | $11.0M | -$1.3M | $33.8M | $6.0M |
| Increase Decrease In Other Current Assets | $150.0K | -$94.0K | -$1.4M | $1.1M | $330.0K | -$510.0K |
| Increase Decrease In Accounts Payable | -$1.1M | -$4.1M | $2.2M | $6.2M | -$1.3M | -$62.0K |
| Increase Decrease In Other Operating Liabilities | -$8.0K | -$99.0K | -$124.0K | -$88.0K | ||
| Proceeds From Issuance Of Common Stock | $11.1M | $37.4M | $0.00 | $32.1M | $3.7M | |
| Payments Of Stock Issuance Costs | $2.0M | $223.0K | ||||
| Depreciation Depletion And Amortization | $9.0K | $37.0K | $60.0K | $106.0K | $46.0K | |
| Net Cash Provided By Used In Investing Activities | -$8.0K | -$298.0K | $0.00 | $791.0K | $1.0M | -$3.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | -$59.0K | $1.1M | $577.0K | $433.0K | $195.0K | $236.0K | $204.0K | $188.0K | |||
| Share Based Compensation | $139.0K | -$32.0K | -$121.0K | $1.1M | $195.0K | ||||||
| Net Cash Provided By Used In Operating Activities | -$2.7M | -$1.4M | -$3.2M | -$5.8M | -$2.6M | ||||||
| Increase Decrease In Prepaid Expense | -$14.0K | -$239.0K | $6.0K | $1.2M | -$155.0K | ||||||
| Increase Decrease In Accrued Liabilities | -$2.0K | $243.0K | $434.0K | -$6.3M | -$32.0K | ||||||
| Net Cash Provided By Used In Financing Activities | $11.1M | $1.4M | $1.2M | $2.3M | |||||||
| Increase Decrease In Other Current Assets | -$5.0K | -$99.0K | $19.0K | -$470.0K | $95.0K | ||||||
| Increase Decrease In Accounts Payable | $177.0K | $2.8M | $198.0K | $5.0M | $108.0K | ||||||
| Increase Decrease In Other Operating Liabilities | -$8.0K | -$23.0K | -$34.0K | ||||||||
| Proceeds From Issuance Of Common Stock | $11.1M | $40.0K | |||||||||
| Payments Of Stock Issuance Costs | |||||||||||
| Depreciation Depletion And Amortization | $11.0K | $2.0K | $23.0K | $56.0K | |||||||
| Net Cash Provided By Used In Investing Activities | $809.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$10.26 | -$3.1K | -$4.19 | |||
| Common Stock Shares Outstanding | 16.1M | 7.3M | 9.8K | 11.4K | 8.1M | 4.3M |
| Common Stock Shares Issued | 19.0M | 7.3M | 9.8K | 11.4K | 8.1M | 4.3M |
| Weighted Average Number Of Shares Outstanding Basic | 14.4M | 1.6M | 3.4K | 6.8K | 6.4M | 3.3M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings Per Share Basic | $-0.78 | $-15.65 | $-6,031.31 | $-3,093.42 | $-4.19 | $-2.03 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.11 | -$22.14 | -$2.03 | -$525.53 | -$6.4K | -$934.29 | -$53.90 | -$19.64 | -$0.17 | -$1.08 | -$0.01 | |||||
| Common Stock Shares Outstanding | 16.1M | 14.6M | 17.0M | 2.8M | 35.0M | 228.5K | 4.2M | 503.6K | 1.2M | 10.3M | 9.3M | 8.8M | 403.8M | |||
| Common Stock Shares Issued | 18.7M | 17.1M | 17.0M | 2.8M | 35.0M | 342.8K | 4.2M | 503.6K | 1.2M | 10.3M | 9.3M | 8.8M | 403.8M | |||
| Weighted Average Number Of Shares Outstanding Basic | 14.7M | 15.5M | 11.1M | 1.6M | 499.3K | 5.8K | 4.1K | 18.6K | 528.00 | 7.2K | 120.2K | 236.8K | 7.8M | 5.0M | 4.5M | 186.2M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | ||||
| Earnings Per Share Basic | $-0.19 | $-0.15 | $-0.25 | $-7.71 | $-3.34 | $-664.16 | $-1,346.09 | $-525.53 | $-6,356.06 | $-934.29 | $-53.90 | $-19.64 | $-0.17 | $-1.08 | $-0.68 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | $757.0K | -$212.0K | $133.0K | -$913.0K | -$95.0K | $62.0K |
| Income Loss Attributable To Parent | -$17.6M | -$26.5M | -$6.4M | |||
| Foreign Currency Transaction Gain Loss Unrealized | -$1.2M | $126.0K | $179.0K | -$450.0K | -$95.0K | $68.0K |
| Interests Expense | -$223.0K | -$499.0K | -$320.0K | |||
| Prepaid Expense Current | $2.1M | $507.0K | $781.0K | $591.0K | $36.0K | $174.0K |
| Interest Paid Net | $0.00 | $423.0K | $34.0K | $85.0K | $262.0K | $40.0K |
| Additional Paid In Capital | $144.2M | $131.1M | $90.4M | $83.2M | $85.2M | $62.5M |
| Stock Issued During Period Value Other | $10.1M | -$2.5M | -$652.0K | |||
| Cumulative Translation Adjustment Net Of Tax Period Increase Decrease | ||||||
| Change In Fair Value Attributable To Instrument Specific Credit Risk | $9.0K | -$9.0K | ||||
| Stock Issued During Period Fair Value Of Instrument Specific Credit Risk | -$9.0K | $9.0K | ||||
| Stock Issued During Period Value New Issues | $38.8M | $3.0M | ||||
| Fair Value Adjustment Of Warrants | $4.2M | $474.0K | $573.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | -$418.0K | $1.6M | $138.0K | $121.0K | -$128.0K | $76.0K | -$156.0K | -$26.0K | $95.0K | -$406.0K | -$269.0K | -$269.0K | $9.0K | -$41.0K | -$39.0K | -$32.0K | ||
| Income Loss Attributable To Parent | -$4.4M | -$2.4M | -$3.4M | -$5.0M | -$5.1M | -$4.3M | -$1.3M | -$5.4M | -$3.1M | -$1.7M | ||||||||
| Foreign Currency Transaction Gain Loss Unrealized | $12.0K | $76.0K | $87.0K | -$255.0K | -$39.0K | |||||||||||||
| Interests Expense | -$33.0K | -$39.0K | -$166.0K | -$79.0K | ||||||||||||||
| Prepaid Expense Current | $1.8M | $1.4M | $493.0K | $151.0K | $366.0K | $542.0K | $396.0K | $220.0K | $315.0K | $491.0K | $876.0K | $1.2M | $125.0K | |||||
| Interest Paid Net | $9.0K | $13.0K | $55.0K | |||||||||||||||
| Additional Paid In Capital | $143.8M | $141.2M | $141.0M | $125.2M | $120.3M | $90.7M | $88.4M | $82.6M | $83.4M | $83.0M | $83.9M | $84.2M | $73.4M | |||||
| Stock Issued During Period Value Other | $639.0K | $6.8M | -$608.0K | $0.00 | -$75.0K | -$79.0K | -$105.0K | |||||||||||
| Cumulative Translation Adjustment Net Of Tax Period Increase Decrease | -$1.0M | -$300.0K | -$542.0K | $1.1M | $371.0K | -$229.0K | ||||||||||||
| Change In Fair Value Attributable To Instrument Specific Credit Risk | $3.0K | $6.0K | ||||||||||||||||
| Stock Issued During Period Fair Value Of Instrument Specific Credit Risk | -$3.0K | -$6.0K | $6.0K | |||||||||||||||
| Stock Issued During Period Value New Issues | $2.5M | $9.7M | $5.4M | $27.7M | $40.0K | -$1.4M | -$133.0K | $3.2M | $12.1M | |||||||||
| Fair Value Adjustment Of Warrants | $4.2M | $201.0K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.